Will 2017's NIS 10 billion budget surplus - the fifth consecutive such annual surplus - be used for cutting government debt or buying voters with tax cuts?
Teva's reliance on Copaxone made the company complacent, obese, and excessively self-confident.
Israel has moved up the World Economic Forum rankings, but has deteriorated according to the World Bank Doing Business index.
Bahrain, Saudi Arabia and Egypt are among the region's countries warming to Israel.
The government is criticizing the high prices charged by toiletries importers while the industry profit margins leader is local manufacturer Sano.
Building starts in 2017 will be far less than Israel needs, despite the government's promises.
Kåre Schultz has turned a company round before, but the challenge at Teva is huge.